LBBW Aktienanleihe MRK 27.09.2024/ DE000LB42QQ4 /
8/26/2024 11:15:10 AM | Chg.0.000 | Bid11:50:32 AM | Ask11:50:32 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
100.200EUR | 0.00% | 100.210 Bid Size: 250,000 |
100.310 Ask Size: 250,000 |
MERCK KGAA O.N. | 140.00 - | 9/27/2024 | Call |
GlobeNewswire
6/3
Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, ...
GlobeNewswire
5/29
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire
5/7
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
5/6
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
3/4
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
12/21/2023
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
12/14/2023
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
10/17/2023
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA